Biodesix, Inc. (BDSX)
NASDAQ: BDSX · Real-Time Price · USD
0.2503
-0.0264 (-9.54%)
At close: Jun 27, 2025, 4:00 PM
0.2652
+0.0149 (5.95%)
After-hours: Jun 27, 2025, 7:51 PM EDT
Biodesix Market Cap
Biodesix has a market cap or net worth of $36.68 million as of June 27, 2025. Its market cap has decreased by -81.14% in one year.
Market Cap
36.68M
Enterprise Value
82.95M
1-Year Change
-81.14%
Ranking
Category
Stock Price
$0.25
Market Cap Chart
Since October 28, 2020, Biodesix's market cap has decreased from $336.31M to $36.68M, a decrease of -89.09%. That is a compound annual growth rate of -37.96%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Jun 18, 2025 | 40.48M | -81.81% |
| Dec 31, 2024 | 222.56M | 33.69% |
| Dec 29, 2023 | 166.48M | -5.38% |
| Dec 30, 2022 | 175.94M | 23.06% |
| Dec 31, 2021 | 142.97M | -73.28% |
| Dec 31, 2020 | 535.07M | 59.10% |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Eli Lilly and Company | 713.81B |
| Johnson & Johnson | 365.75B |
| AbbVie | 329.95B |
| Novo Nordisk | 299.93B |
| UnitedHealth Group | 274.52B |
| Novartis AG | 235.02B |
| Abbott Laboratories | 232.56B |
| AstraZeneca | 215.99B |